Search Results for "Brilinta Sales"

20:00 EDT 28th May 2016 | BioPortfolio

Matching Channels

Brilinta (TM) - ticagrelor, AstraZeneca's new heart drug

Brilinta - ticagrelor, AstraZeneca's new heart drug is a blood-thinning medicine designed to prevent dangerous blood clots in patients with serious chest pain or previous heart attacks. It re...

Sales Jobs


OxyContin, an narcotic <!--LGfEGNT2Lhm-->analgesic produced by Purdue Pharma LP, nets $3m in <!--LGfEGNT2Lhm-->sales annually, placing it 8th in the world for annual sales. OxyContin i...

GE Healthcare

Ranked as the third largest medical device company in the world (based on annual sales), GE Healthcare generates $16 billion in sales each year. GEs' area of expertise is the imaging that is i...


Siemens Healthcare is the second largest medical devices company in the world (based on annual sales), with sales of $17.4 billion. Specializing in the imaging, IT, diagnostics and workflow soluti...

Matching News

Brilinta preferred over clopidogrel in new guideline for heart attack patients

Anglo-Swedish pharma major AstraZeneca has welcomed a new treatment guideline which recommends its Brilinta…

Brilinta No Better Than Aspirin In Stroke Trial

Topline data from the SOCRATES trial of Brilinta (Brilique; ticagrelor) provided more ammunition for those pushing for AstraZeneca's CEO Pascal Soriot to have his pay linked to performance.

BRIEF-Astrazeneca says Brilinta Socrates study misses main goal

* Astrazeneca reports top-line results from Brilinta Socrates trial in stroke

BRIEF-AstraZeneca says ACC, AHA guidelines prefer Brilinta over clopidogrel

* Brilinta preferred over clopidogrel in updated American College of Cardiology, American Heart Association guideline in acute coronary syndrome Source text : Further company cov...

Rückschlag für Astrazeneca beim Hoffnungsträger Brilinta

Von Denise Roland LONDON (Dow Jones)--Der Pharmakonzern Astrazeneca hat bei einem seiner Hoffnungsträger ein enttäuschendes Studienergebnis verzeichnet. Der Blutverdünner Brilinta ist beim Einsatz....

AstraZeneca's heart drug Brilinta fails in stroke trial

AstraZeneca said its Brilinta heart drug has failed to show a significant benefit in patients suffering with acute ischaemic stroke.

FDA: Brintellix changing name to avoid confusion with brilinta

(HealthDay)—Following a July 2015 Drug Safety Communication that warned about name confusion between Brintellix and Brilinta resulting in prescribing errors, the antidepressant Brintellix (vortioxet...

AZ's key drug Brilique fails in stroke trial

AstraZeneca's Brilinta/Brilique (ticagrelor) has failed to improve on aspirin in a cardiovascular event trial, according to top line results announced today. The news will put a dent in AZ's hopes for...

Matching PubMed Articles

The Impact of Restricting Over-the-Counter Sales of Antimicrobial Drugs: Preliminary Analysis of National Data.

To describe the nationwide impact of a restrictive law on over-the-counter sales of antimicrobial drugs, implemented in Brazil in November 2010.Approximately 75% of the population receives healthcare ...

Tracking Cholera through Surveillance of Oral Rehydration Solution Sales at Pharmacies: Insights from Urban Bangladesh.

In Bangladesh, pharmacy-purchased oral rehydration solution (ORS) is often used to treat diarrhea, including cholera. Over-the-counter sales have been used for epidemiologic surveillance in the past, ...

Sales promotion strategies and youth drinking in Australia.

This study employed an exploratory approach to generate detailed information about how in-store shopping experiences and exposure to sales promotion activities feature in the alcohol choices of Austra...

Estimation of the unregistered inflow of electrical and electronic equipment to a domestic market: a case study on televisions in Vietnam.

Waste electrical and electronic equipment (WEEE) constitutes one of the most problematic waste streams worldwide, and accurately estimating the scale of WEEE can assist in tackling its associated issu...

Evaluation of concentrations of pharmaceuticals detected in sewage influents in Japan by using annual shipping and sales data.

A year-round monitoring survey of sewage flowing into sewage treatment plants located in urban Japan was conducted by targeting seven representative pharmaceutical components-atenolol (ATL), ciproflox...

Search Whole site using Google

Quick Search
Advertisement Advertisement